ArticleJournal of the National Cancer Institute2012

CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.

James M Rae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.